menu ☰
menu ˟

Next-generation TAVR system receives CE mark

24 Sep 2016
Boston Scientific announced its next-generation transcatheter aortic valve replacement system has received a CE mark and can now be used in Europe in patients with severe aortic stenosis at high risk for surgery. The system (Lotus Edge, Boston Scient...

Click here to view the full article which appeared in Cardiology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.